| 0 |
AUDITORY NERVE DISORDER |
1 |
0.0227 |
| 1 |
EOSINOPHILIC PUSTULAR FOLLICULITIS |
1 |
0.0108 |
| 2 |
DISCONTINUED PRODUCT ADMINISTERED |
3 |
0.0091 |
| 3 |
SPINAL CLAUDICATION |
1 |
0.0085 |
| 4 |
SERRATIA BACTERAEMIA |
1 |
0.0068 |
| 5 |
FEAR-RELATED AVOIDANCE OF ACTIVITIES |
1 |
0.0066 |
| 6 |
PHLEBOLITH |
1 |
0.0059 |
| 7 |
ANORECTAL SWELLING |
1 |
0.0044 |
| 8 |
BONE DEMINERALISATION |
4 |
0.0038 |
| 9 |
CONVULSIVE THRESHOLD LOWERED |
1 |
0.0025 |
| 10 |
FRACTURED SACRUM |
2 |
0.0016 |
| 11 |
CENTRAL OBESITY |
1 |
0.0014 |
| 12 |
INFECTION PARASITIC |
1 |
0.0013 |
| 13 |
HYPERPARATHYROIDISM SECONDARY |
3 |
0.0012 |
| 14 |
FANCONI SYNDROME ACQUIRED |
2 |
0.0011 |
| 15 |
PRODUCT AFTER TASTE |
1 |
0.0010 |
| 16 |
OSTEOPOROTIC FRACTURE |
2 |
0.0010 |
| 17 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
1 |
0.0009 |
| 18 |
SOMATIC SYMPTOM DISORDER |
1 |
0.0009 |
| 19 |
NOROVIRUS INFECTION |
1 |
0.0007 |
| 20 |
OSTEOMALACIA |
1 |
0.0006 |
| 21 |
DRUG TOLERANCE |
3 |
0.0006 |
| 22 |
WOUND INFECTION STAPHYLOCOCCAL |
1 |
0.0006 |
| 23 |
HYPERPHOSPHATAEMIA |
1 |
0.0005 |
| 24 |
OSTEOPENIA |
7 |
0.0005 |
| 25 |
RENAL TUBULAR ACIDOSIS |
1 |
0.0005 |
| 26 |
ANHEDONIA |
12 |
0.0005 |
| 27 |
GASTROINTESTINAL ULCER |
1 |
0.0005 |
| 28 |
ECONOMIC PROBLEM |
6 |
0.0004 |
| 29 |
FIBULA FRACTURE |
1 |
0.0003 |
| 30 |
ANAL INCONTINENCE |
3 |
0.0003 |
| 31 |
HYPOPNOEA |
1 |
0.0003 |
| 32 |
BONE LOSS |
4 |
0.0003 |
| 33 |
AZOTAEMIA |
1 |
0.0003 |
| 34 |
SPINAL OPERATION |
3 |
0.0002 |
| 35 |
PHYSICAL DISABILITY |
1 |
0.0002 |
| 36 |
WHEELCHAIR USER |
1 |
0.0002 |
| 37 |
END STAGE RENAL DISEASE |
4 |
0.0002 |
| 38 |
INTERVERTEBRAL DISC DEGENERATION |
2 |
0.0002 |
| 39 |
TIBIA FRACTURE |
1 |
0.0002 |
| 40 |
MEDICATION RESIDUE PRESENT |
1 |
0.0002 |
| 41 |
HYPOVOLAEMIC SHOCK |
1 |
0.0002 |
| 42 |
ANEURYSM |
1 |
0.0002 |
| 43 |
VULVOVAGINAL PRURITUS |
1 |
0.0002 |
| 44 |
PATHOLOGICAL FRACTURE |
1 |
0.0002 |
| 45 |
OSTEOPOROSIS |
8 |
0.0002 |
| 46 |
FOOD POISONING |
1 |
0.0002 |
| 47 |
DECREASED ACTIVITY |
2 |
0.0002 |
| 48 |
STRESS FRACTURE |
1 |
0.0002 |
| 49 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 50 |
FRACTURE |
3 |
0.0002 |
| 51 |
OSTEONECROSIS |
5 |
0.0002 |
| 52 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 53 |
HAND FRACTURE |
1 |
0.0001 |
| 54 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 55 |
SENSITIVE SKIN |
1 |
0.0001 |
| 56 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 57 |
DRUG EFFECT LESS THAN EXPECTED |
2 |
0.0001 |
| 58 |
CHRONIC KIDNEY DISEASE |
10 |
0.0001 |
| 59 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 60 |
ANKLE FRACTURE |
2 |
0.0001 |
| 61 |
BONE DENSITY DECREASED |
4 |
0.0001 |
| 62 |
GASTROINTESTINAL INFLAMMATION |
1 |
0.0001 |
| 63 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 64 |
RENAL CYST |
1 |
0.0001 |
| 65 |
ABNORMAL FAECES |
1 |
0.0001 |
| 66 |
HICCUPS |
1 |
0.0001 |
| 67 |
MULTIPLE FRACTURES |
2 |
0.0001 |
| 68 |
EMOTIONAL DISTRESS |
14 |
0.0001 |
| 69 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 70 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 71 |
MENTAL STATUS CHANGES |
3 |
0.0001 |
| 72 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 73 |
NEPHROPATHY |
1 |
0.0001 |
| 74 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 75 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 76 |
FLATULENCE |
6 |
0.0001 |
| 77 |
SPINAL DISORDER |
1 |
0.0001 |
| 78 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 79 |
RENAL TUBULAR NECROSIS |
1 |
0.0001 |
| 80 |
PRODUCT DOSE OMISSION ISSUE |
29 |
0.0001 |
| 81 |
SKELETAL INJURY |
1 |
0.0001 |
| 82 |
TOOTH LOSS |
2 |
0.0001 |
| 83 |
JOINT DISLOCATION |
1 |
0.0001 |
| 84 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 85 |
SKIN LACERATION |
1 |
0.0001 |
| 86 |
INTERNAL HAEMORRHAGE |
1 |
0.0001 |
| 87 |
DIABETIC KETOACIDOSIS |
2 |
0.0001 |
| 88 |
TOOTH EXTRACTION |
1 |
0.0001 |
| 89 |
HYPOPHAGIA |
2 |
0.0001 |
| 90 |
BEDRIDDEN |
1 |
0.0001 |
| 91 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 92 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 93 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 94 |
ABNORMAL DREAMS |
2 |
0.0001 |
| 95 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 96 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 97 |
INTENTIONAL DOSE OMISSION |
2 |
0.0001 |
| 98 |
OFF LABEL USE |
61 |
0.0001 |
| 99 |
NEPHROLITHIASIS |
3 |
0.0001 |
| 100 |
DEVICE RELATED INFECTION |
1 |
0.0001 |
| 101 |
FEMUR FRACTURE |
2 |
0.0001 |
| 102 |
DELUSION |
1 |
0.0001 |
| 103 |
BRAIN FOG |
1 |
0.0001 |
| 104 |
ABSCESS |
1 |
0.0001 |
| 105 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
3 |
0.0001 |
| 106 |
HIP FRACTURE |
2 |
0.0001 |
| 107 |
MANIA |
1 |
0.0001 |
| 108 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 109 |
RENAL IMPAIRMENT |
5 |
0.0001 |
| 110 |
PARANOIA |
1 |
0.0001 |
| 111 |
THIRST |
1 |
0.0001 |
| 112 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 113 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 114 |
COLITIS |
2 |
0.0001 |
| 115 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 116 |
ERUCTATION |
1 |
0.0001 |
| 117 |
SPINAL FRACTURE |
1 |
0.0000 |
| 118 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 119 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 120 |
ANXIETY |
14 |
0.0000 |
| 121 |
RIB FRACTURE |
1 |
0.0000 |
| 122 |
JOINT INJURY |
1 |
0.0000 |
| 123 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 124 |
RHINORRHOEA |
3 |
0.0000 |
| 125 |
RENAL FAILURE |
6 |
0.0000 |
| 126 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 127 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 128 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 129 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 130 |
HYPOKALAEMIA |
2 |
0.0000 |
| 131 |
RENAL DISORDER |
2 |
0.0000 |
| 132 |
THERAPY INTERRUPTED |
3 |
0.0000 |
| 133 |
CONSTIPATION |
9 |
0.0000 |
| 134 |
DIARRHOEA |
26 |
0.0000 |
| 135 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 136 |
HAEMATEMESIS |
1 |
0.0000 |
| 137 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 138 |
DRUG INEFFECTIVE |
51 |
0.0000 |
| 139 |
ABDOMINAL DISTENSION |
4 |
0.0000 |
| 140 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 141 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 142 |
DEPRESSION |
8 |
0.0000 |
| 143 |
HYPERSOMNIA |
1 |
0.0000 |
| 144 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 145 |
SURGERY |
2 |
0.0000 |
| 146 |
NASAL CONGESTION |
2 |
0.0000 |
| 147 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 148 |
RENAL INJURY |
1 |
0.0000 |
| 149 |
HOSPITALISATION |
5 |
0.0000 |
| 150 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 151 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 152 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 153 |
BLOOD CREATININE INCREASED |
2 |
0.0000 |
| 154 |
BACK PAIN |
7 |
0.0000 |
| 155 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 156 |
DEHYDRATION |
4 |
0.0000 |
| 157 |
SKIN DISORDER |
1 |
0.0000 |
| 158 |
PRODUCT USE IN UNAPPROVED INDICATION |
7 |
0.0000 |
| 159 |
PAIN |
17 |
0.0000 |
| 160 |
EYE SWELLING |
1 |
0.0000 |
| 161 |
DEATH |
23 |
0.0000 |
| 162 |
PROSTATE CANCER |
2 |
0.0000 |
| 163 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 164 |
POLLAKIURIA |
1 |
0.0000 |
| 165 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 166 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 167 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 168 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 169 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 170 |
TINNITUS |
1 |
0.0000 |
| 171 |
SWELLING |
2 |
0.0000 |
| 172 |
ANAEMIA |
4 |
0.0000 |
| 173 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 174 |
DIZZINESS |
10 |
0.0000 |
| 175 |
FLUSHING |
2 |
0.0000 |
| 176 |
ACUTE KIDNEY INJURY |
3 |
0.0000 |
| 177 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 178 |
INFLUENZA |
2 |
0.0000 |
| 179 |
SEPSIS |
2 |
0.0000 |
| 180 |
WEIGHT INCREASED |
4 |
0.0000 |
| 181 |
COUGH |
5 |
0.0000 |
| 182 |
HYPONATRAEMIA |
1 |
0.0000 |
| 183 |
LETHARGY |
1 |
0.0000 |
| 184 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 185 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 186 |
JOINT SWELLING |
2 |
0.0000 |
| 187 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 188 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 189 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 190 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 191 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 192 |
FATIGUE |
11 |
0.0000 |
| 193 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 194 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 195 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 196 |
DYSGEUSIA |
1 |
0.0000 |
| 197 |
EPISTAXIS |
1 |
0.0000 |
| 198 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 199 |
ARTHRITIS |
1 |
0.0000 |
| 200 |
PARAESTHESIA |
2 |
0.0000 |
| 201 |
CARDIAC FAILURE |
1 |
0.0000 |
| 202 |
THROMBOSIS |
1 |
0.0000 |
| 203 |
ARTHRALGIA |
5 |
0.0000 |
| 204 |
MYALGIA |
2 |
0.0000 |
| 205 |
RASH |
5 |
0.0000 |
| 206 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 207 |
MALAISE |
5 |
0.0000 |
| 208 |
COVID-19 |
2 |
0.0000 |
| 209 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 210 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 211 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 212 |
ADVERSE EVENT |
1 |
0.0000 |
| 213 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 214 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 215 |
DYSPHAGIA |
1 |
0.0000 |
| 216 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 217 |
PRURITUS |
4 |
0.0000 |
| 218 |
CONTUSION |
1 |
0.0000 |
| 219 |
DYSPEPSIA |
1 |
0.0000 |
| 220 |
HEART RATE INCREASED |
1 |
0.0000 |
| 221 |
SYNCOPE |
1 |
0.0000 |
| 222 |
HYPOTENSION |
2 |
0.0000 |
| 223 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 224 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 225 |
SINUSITIS |
1 |
0.0000 |
| 226 |
FALL |
3 |
0.0000 |
| 227 |
ASTHMA |
1 |
0.0000 |
| 228 |
DECREASED APPETITE |
2 |
0.0000 |
| 229 |
CHILLS |
1 |
0.0000 |
| 230 |
NAUSEA |
6 |
0.0000 |
| 231 |
WEIGHT DECREASED |
2 |
0.0000 |
| 232 |
HYPOAESTHESIA |
1 |
0.0000 |
| 233 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 234 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 235 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 236 |
MUSCLE SPASMS |
1 |
0.0000 |
| 237 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 238 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 239 |
ALOPECIA |
1 |
0.0000 |
| 240 |
SOMNOLENCE |
1 |
0.0000 |
| 241 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 242 |
HEADACHE |
3 |
0.0000 |
| 243 |
HYPERTENSION |
1 |
0.0000 |
| 244 |
OVERDOSE |
1 |
0.0000 |
| 245 |
VOMITING |
2 |
0.0000 |
| 246 |
INSOMNIA |
1 |
0.0000 |
| 247 |
DYSPNOEA |
2 |
0.0000 |
| 248 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 249 |
PYREXIA |
1 |
0.0000 |